206
Views
3
CrossRef citations to date
0
Altmetric
Review Article

Botulism in pregnancy – a clinical approach to diagnosis and management

Pages 3125-3132 | Received 10 Feb 2018, Accepted 22 Mar 2018, Published online: 06 Apr 2018

References

  • Sobel J. Botulism. Clin Infect Dis. 2005;41(8):1167–1173.
  • Black RE, Arnon SS. Botulism in the United States, 1976. J Infect Dis. 1977;136(6):829–832.
  • Shapiro RL, Hatheway C, Swerdlow DL. Botulism in the United States: a clinical and epidemiologic review. Ann Intern Med. 1998;129(3):221–228.
  • Prowse CM, Gaensler EAL. Respiratory and acid-base changes during pregnancy. Anesthesiology. 1965;26:381–392.
  • Templeton A, Kelman GR. Maternal blood-gases, (PAO2 −PaO2), Physiological shunt and VD/VT in normal pregnancy. Br J Anaesth. 1976;48(10):1001–1004.
  • Klaften E, Palugyay J. Vergleichende Untersuchungen über Lage und Ausdehnung von Herz und Lunge in der Schwangerschaft und im Wochenbett. Arch Gynak. 1927;131(2):347–363.
  • Klaften E, Palugyay J. Zur Physiologie der Atmung in der Schwangerschaft. Arch Gynak. 1926;129(2):414–424.
  • Mobius WV. Abrung und Schwangerschaft. Münch Med Wochenschr. 1961;103:1389.
  • Badell ML, Rimawi BH, Rao AK, et al. Botulism during pregnancy and the postpartum period: A systematic review. Clin Infect Dis. 2018;66(suppl_1):S30–S37.
  • Simpson LL. Molecular pharmacology of botulinum toxin and tetanus toxin. Annu Rev Pharmacol Toxicol. 1986;26:427–453.
  • Magri K, Bresson V, Barbier C. Botulism and pregnancy. J Gynecol Obstet Biol Reprod. 2006;35(6):624–626.
  • Dolman CE, Darby GE, Lane RF. Type E botulism due to salmon eggs. Can J Public Health. 1955;46:135–141.
  • Audet D, Landry Y, Gauvreau L, et al. Type E botulism. 2 Epidemics at Fort Chimo [in French]. Union Med Can. 1973;103(8):1726–1737.
  • Armstrong RW, Stenn F, Dowell VR Jr., et al. Type E botulism from home-canned gefilte fish. Report of three cases. JAMA. 1969;210(2):303–305.
  • Robin L, Herman D, Redett R. Botulism in a pregnant woman. N Engl J Med. 1996;335(11):823–824.
  • Götz J, Carlsson J, Schipmann R, et al. [37-year-old patient with eye muscle paralysis and rapidly progressing respiratory insufficiency]. Internist. 2002;43(4):548–553.
  • Morrison GA, Lang C, Huda S. Botulism in a pregnant intravenous drug abuser. Anaesthesia. 2006;61(1):57–60.
  • Centers for Disease Control and Prevention (CDC). Wound botulism–California, 1995. MMWR Morb Mortal Wkly Rep. 1995;44(48):889–892.
  • MacDonald KL, Cohen ML, Blake PA. The changing epidemiology of adult botulism in the United States. Am J Epidemiol. 1986;124(5):794–799.
  • O’Brien M, Foertner P, Boyle AF, et al. Botulism. MMWR Morb Mortal Wkly Rep. 1973;22–26.
  • St. Clair EH, DiLiberti JH, O’Brien ML. Letter. observations of an infant born to a mother with botulism. J Pediatr. 1975; 87:658.
  • Erlebacher A. Immune surveillance of the maternal/fetal interface: controversies and implications. Trends Endocrinol Metab. 2010;21(7):428–434.
  • Dressler D, Saberi FA, Barbosa ER. Botulinum toxin: mechanisms of action. Arq Neuropsiquiatr. 2005;63(1):180–185.
  • Dembek ZF, Smith LA, Rusnak JM. Botulism: cause, effects, diagnosis, clinical and laboratory identification, and treatment modalities. Disaster Med Public Health Prep. 2007;1(2):122–134.
  • US Food and Drug Administration. FDA approves first botulism antitoxin for use in neutralizing all seven known botulinum nerve toxin serotypes. FDA. [cited 2013 Mar 22]. Available from: https://www.fda.gov/BiologicsBloodVaccines/BloodBloodProducts/ApprovedProducts/LicensedProductsBLAs/FractionatedPlasmaProducts/ucm345134.htm.
  • Davis LE. Normal laboratory values of CSF during pregnancy. Arch Neurol. 1979;36(7):443.
  • Giles D, Hewitt D, Stewart A, et al. Malignant disease in childhood and diagnostic irradiation in utero. Lancet. 1956;271(6940):447.
  • Streffer C, Shore R, Konermann G, et al. Biological effects after prenatal irradiation (embryo and fetus): a report of the International Commission on Radiological Protection. Ann ICRP. 2003;33(1–2):5–206.
  • Lowe SA. Diagnostic radiography in pregnancy: risks and reality. Aust NZJ Obstet Gynaecol. 2004;44(3):191–196.
  • Chapon C, Franconi F, Roux J, et al. Prenatal evaluation of kidney function in mice using dynamic contrast-enhanced magnetic resonance imaging. Anat Embryol. 2005;209(4):263–267.
  • Buhimschi C, Boyle MB, Garfield RE. Electrical activity of the human uterus during pregnancy as recorded from the abdominal surface. Obstet Gynecol. 1997;90(1):102–111.
  • Landauer W. Cholinomimetic teratogens: studies with chicken embryos. Teratology. 1975;12(2):125–145.
  • Hay DM. Myasthenia gravis and pregnancy. J Obstet Gynaecol Br Commonw. 1969;76(4):323–329.
  • Willison HJ, Yuki N. Peripheral neuropathies and anti-glycolipid antibodies. Brain. 2002;125(Pt 12):2591–2625.
  • Bowell PJ, Allen DL, Entwistle CC. Blood group antibody screening tests during pregnancy. Br J Obstet Gynaecol. 1986; 93(10):1038–1043.
  • Gazioglu K, Kaltreider NL, Rosen M, et al. Pulmonary function during pregnancy in normal women and in patients with cardiopulmonary disease. Thorax. 1970;25(4):445–450.
  • American College of Obstetrics and Gynecology. ACOG practice bulletin. Obstetric analgesia and anesthesia. Number 177, April 2017. Obstet Gynecol. 2017;129(4):e73–ee89.
  • Soghoyan A, Baklavajyan M, Minasyan A, et al. Case of neurobotulism in pregnant women. J Neurol. 2012;259:143–144.
  • Polo JM, Martin J, Berciano J. Botulism and pregnancy. Lancet. 1996;348(9021):195.
  • Krichevsky YA, Parafeinik GM, Lifshits LA. Clinical aspects and treatment of botulism. Hosp Practice. 1964;11:97–99.
  • Lopez T, Alburquerque JSB, Monzoin Corral L. Botulism caused by candy for children. Rev Esp Pediatr. 1988;44:421–423.
  • Rabeau E. Botulism in Arctic Alaska. Report of 13 cases with 5 fatalities. Alaska Med. 1959;1:6–9.
  • Podesta C. Asistencia respiratoria en el botulismo. Rev Asoc Med Argent. 1960;2:462–467.
  • Roberts D, Dalziel S, Brown J, et al. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Review. Cochrane Database Syst Rev 2006:CD004454.
  • Society for Maternal-Fetal Medicine (SMFM). Implementation of the use of antenatal corticosteroids in the late preterm birth period in women at risk for preterm delivery. Am J Obstet Gynecol. 2016;215(2):B13–B15.
  • American College of Obstetricians and Gynecologists Committee on Obstetric Practice, Society of Maternal Fetal Medicine, Society for Maternal-Fetal Medicine. Committee Opinion No. 455: magnesium sulfate before anticipated preterm birth for neuroprotection. Obstet Gynecol. 2010;115(3):669–671.
  • Preboth M. ACOG guidelines on antepartum fetal surveillance. American College of Obstetricians and Gynecologists. Am Fam Phys. 2000;62(5):1187–1188.
  • Barbour LA, ACOG Committee on Practice Bulletins. ACOG practice bulletin. Thrombembolism in pregnancy. Int J Gynecol Obstet. 2001;75(2):203–212.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.